DNA

Ginkgo BioworksD

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

20%

Probability

Target price

$12.00

+28.6% vs current

Most likely

Base case

50%

Probability

Target price

$8.00

-14.3% vs current

B-

Bear case

30%

Probability

Target price

$4.00

-57.1% vs current

AI sentiment snapshot

Latest data as of 2026-05-20

AI commentary

News flow is concentrated in the May 7 Q1 filing and press release, with no analyst revision wave or clean consensus update surfaced in the packet. The read stays cautious and tentative: liquidity was preserved and burn guidance was reiterated, but core revenue fell sharply, autonomous-lab monetization is still a longer-dated thesis, and the available peer set is a loose small-cap healthcare screen rather than direct operating comparators [#8-K-2026-05-07][#10-Q-2026-05-07].

RankAlpha Sentiment Codex - 2026-05-20

Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators; small-cap biotech peer set is too weak or includes unrelated comparators for a standard-conviction report

Impact

tentative

Confidence

AI events

2026-05-07eventQ1 2026 print showed weaker revenue but preserved liquidityMedium impact

The May 7 8-K/press release reported Q1 revenue of $19 million, down about 49% year over year, with the decline mainly tied to ongoing program rationalization; continuing-operations net loss was $(76.1) million, adjusted EBITDA was $(42) million, and cash, cash equivalents, and marketable securities were $373 million at March 31, 2026 [#8-K-2026-05-07][#10-Q-2026-05-07].

2026-12-31catalystAutonomous-lab scaling and partner traction remain the main long-term optionHigh impact

Management said Nebula is the world's largest autonomous lab, is targeting a doubling of its size in 2026, and is seeing Cloud Lab traction from partners such as ProQR and Amazon, which gives the stock a specific platform and partnership milestone to monitor even though near-term revenue remains small [#8-K-2026-05-07].

2026-12-31catalyst2026 cash-burn execution is the key financing and runway checkpointHigh impact

Ginkgo reaffirmed expected total 2026 cash burn of $(150) million to $(125) million after reporting $373 million of cash, cash equivalents, and marketable securities at March 31, 2026, so evidence that burn remains inside that range would support runway credibility while a miss would revive financing concerns [#8-K-2026-05-07].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-20 • Updated nightlySource: Internal modelMethodology